A Red-Hot Tesla Burns Rubber on Consumer Reports
The Tesla Model S P85D sedan just broke the Consumer Reports rating system.
By definition, a car can’t exceed a score of 100 on the road test. But after the P85D racked up a score of 103, Consumer Reports was forced to create a new benchmark for the system and overhaul the ratings process according to a news release. The new system caused the car to slip to a score of 100.
A few characteristics of the car that allowed it to perform better in the test than any other car ever before include its rapid acceleration ability (0 to 60 mph in 3.5 seconds), its remarkable energy-efficiency (the car gets the equivalent of 87 miles per gallon) and its better breaking and handling system than the former top-scoring standard Model S. Two years ago, the base model version of the Model S received a 99 out of 100, which at the time was the highest rating ever for a vehicle.
Related: Why Americans Are Keeping Their Cars Longer Than Ever
The report is careful to note that even with a perfect score, the Tesla isn’t a perfect car. Besides a price tag of $127,820, beyond the means of the average person and the most expensive car Consumer Reports has ever reviewed, the car is louder than the base Model S and isn’t as plush as other luxury vehicles.
In addition, a long drive might be problematic if there aren’t any nearby charging stations along the route due to the vehicle’s 200-plus mile range. The rating also doesn’t account for the Tesla’s reliability, but the Model S comes with average reliability, according to owner-survey responses.
Imperfections aside, the car received an enviable final assessment. “It’s a remarkable car that paves a new, unorthodox course, and it’s a powerful statement of American startup ingenuity,” the report reads.
Chart of the Day: Boosting Corporate Tax Revenues
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
Chart of the Day: Discretionary Spending Droops
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
Chart of the Week: Trump Adds $4.7 Trillion in Debt
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Chart of the Day: The Long Decline in Interest Rates
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Chart of the Day: Drug Price Plans Compared
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.
